Veno Occlusive Disease News and Research

RSS
Identifying risk biomarkers for a serious side effect of stem cell transplants

Identifying risk biomarkers for a serious side effect of stem cell transplants

Gene therapy leads to durable transfusion independence in youngest patients with thalassemia

Gene therapy leads to durable transfusion independence in youngest patients with thalassemia

Molecular approach can improve diagnosis of pulmonary hypertension

Molecular approach can improve diagnosis of pulmonary hypertension

Clinical trial to test the efficacy of defibrotide medicine for reducing COVID-19 death rate

Clinical trial to test the efficacy of defibrotide medicine for reducing COVID-19 death rate

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Researchers develop quick and easy-to-use test for detecting rare immunodeficiency

Researchers develop quick and easy-to-use test for detecting rare immunodeficiency

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Experts develop new genomic testing method for pulmonary hypertension caused by genetic mutation

Experts develop new genomic testing method for pulmonary hypertension caused by genetic mutation

Salvage inotuzumab ozogamicin improves ALL outcomes

Salvage inotuzumab ozogamicin improves ALL outcomes

FDA approves Defitelio to treat hepatic veno-occlusive disease in adults, children

FDA approves Defitelio to treat hepatic veno-occlusive disease in adults, children

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

HCT not precluded by prior second-generation TKI therapy in chronic, advanced phase CML

Jazz Pharmaceuticals to present defibrotide results for hepatic VOD at BMT Tandem meetings

Jazz Pharmaceuticals to present defibrotide results for hepatic VOD at BMT Tandem meetings

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare receives FDA approval for Adempas tablets

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.